This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignees: Genentech, Inc., Hoffmann-La Roche Inc.. Active years: 2024.
Company Filing History:
1 out of 3,294 
1 out of 5,020 
Years Active: 2024
Title: Raphael Bigler: Innovator in Quinazoline Synthesis
Introduction
Raphael Bigler is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of chemistry, particularly in the synthesis of quinazoline compounds. His innovative work has led to the development of methods that involve at least one atropisomeric center.
Latest Patents
Raphael Bigler holds 1 patent for his work titled "Synthesis of quinazoline compounds." This patent outlines methods for synthesizing quinazoline compounds, which are essential in various chemical applications.
Career Highlights
Throughout his career, Raphael has worked with prominent companies in the pharmaceutical industry, including Hoffmann-La Roche Inc. and Genentech, Inc. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research.
Collaborations
Raphael has collaborated with esteemed colleagues such as Nicholas Andrew White and Etienne Trachsel. These partnerships have further enhanced his research and development efforts in the field of chemistry.
Conclusion
Raphael Bigler is a distinguished inventor whose work in quinazoline synthesis has made a lasting impact in the field of chemistry. His innovative methods and collaborations with leading companies and professionals highlight his significant contributions to scientific advancement.